Literature DB >> 25081090

Maintaining dendritic cell viability in culture.

David Vremec1, Jacinta Hansen1, Andreas Strasser2, Hans Acha-Orbea3, Yifan Zhan1, Meredith O'Keeffe4, Ken Shortman5.   

Abstract

When mouse dendritic cells (DCs) are isolated from tissues, purified and placed in a nutritive culture they die more rapidly than would be expected from their normal turnover in vivo. This can distort culture assays of DC function. We therefore tested several approaches to prolonging DC survival in culture. Of several cytokines tested granulocyte-macrophage colony stimulating factor was most effective at preserving the viability of conventional DCs (cDCs) but was ineffective for plasmacytoid DCs (pDCs). Surprisingly, Fms-like tyrosine kinase 3 ligand, crucial for DC development, produced only a marginal improvement in DC survival in culture, and interleukin-3, reported to prevent apoptosis of human pDCs, produced only a minor improvement in survival of mouse DCs. Genetic manipulation of cell death pathways was also tested, to avoid activation effects exerted by cytokine signalling. The isolation of DCs from mice overexpressing Bcl-2 was especially effective in maintaining pDC viability but gave a lesser improvement in cDC viability. DCs isolated from Bim(-/-)Noxa(-/-) mice also showed improved culture survival, but in this case with pDCs showing the least improvement. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines and DC survival; DC death; DC death pathways; pDC death

Mesh:

Substances:

Year:  2014        PMID: 25081090     DOI: 10.1016/j.molimm.2014.07.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets.

Authors:  Pooja Arora; Steven A Porcelli
Journal:  J Vis Exp       Date:  2016-04-18       Impact factor: 1.355

2.  Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival.

Authors:  Simon J Tavernier; Fabiola Osorio; Lana Vandersarren; Jessica Vetters; Nele Vanlangenakker; Gert Van Isterdael; Karl Vergote; Riet De Rycke; Eef Parthoens; Lianne van de Laar; Takao Iwawaki; Juan R Del Valle; Chih-Chi Andrew Hu; Bart N Lambrecht; Sophie Janssens
Journal:  Nat Cell Biol       Date:  2017-05-01       Impact factor: 28.824

3.  Prosurvival Bcl-2 family members reveal a distinct apoptotic identity between conventional and plasmacytoid dendritic cells.

Authors:  Emma M Carrington; Jian-Guo Zhang; Robyn M Sutherland; Ingela B Vikstrom; Jamie L Brady; Priscilla Soo; David Vremec; Cody Allison; Erinna F Lee; W Douglas Fairlie; Philippe Bouillet; Stephanie Grabow; Eleonora Ottina; Marco J Herold; Marc Pellegrini; David C S Huang; David M Tarlinton; Andreas Strasser; Andrew M Lew; Yifan Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

Review 4.  Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions.

Authors:  Liv Eidsmo; Elisa Martini
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

5.  Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell Line.

Authors:  Matteo Pigni; Devika Ashok; Mathias Stevanin; Hans Acha-Orbea
Journal:  Front Immunol       Date:  2018-08-24       Impact factor: 7.561

Review 6.  Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions.

Authors:  Thien-Phong Vu Manh; Nicolas Bertho; Anne Hosmalin; Isabelle Schwartz-Cornil; Marc Dalod
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

7.  Plasmacytoid dendritic cells are short-lived: reappraising the influence of migration, genetic factors and activation on estimation of lifespan.

Authors:  Yifan Zhan; Kevin V Chow; Priscilla Soo; Zhen Xu; Jamie L Brady; Kate E Lawlor; Seth L Masters; Meredith O'keeffe; Ken Shortman; Jian-Guo Zhang; Andrew M Lew
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.